Business Description
PExA AB
ISIN : SE0007412374
Share Class Description:
FRA:FA0: Class BCompare
Compare
Traded in other countries / regions
PEXA B.SwedenFA0.Germany IPO Date
2023-07-14Description
PExA AB develops, manufactures, and markets a research tool for studying respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). Its product includes PExA 2.0.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.78 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -2.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.5 | |||||
| 3-Year EBITDA Growth Rate | 22.2 | |||||
| 3-Year EPS without NRI Growth Rate | 25.4 | |||||
| 3-Year FCF Growth Rate | 22.8 | |||||
| 3-Year Book Growth Rate | -19.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.29 | |||||
| 9-Day RSI | 50.33 | |||||
| 14-Day RSI | 49.93 | |||||
| 6-1 Month Momentum % | -5.26 | |||||
| 12-1 Month Momentum % | -22.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.16 | |||||
| Quick Ratio | 2.81 | |||||
| Cash Ratio | 2.29 | |||||
| Days Inventory | 979.31 | |||||
| Days Sales Outstanding | 97.85 | |||||
| Days Payable | 196.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 9.75 | |||||
| Operating Margin % | -716.22 | |||||
| Net Margin % | -668.93 | |||||
| FCF Margin % | -726.09 | |||||
| ROE % | -67.26 | |||||
| ROA % | -57.77 | |||||
| ROIC % | -205.57 | |||||
| ROC (Joel Greenblatt) % | -388.48 | |||||
| ROCE % | -68.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 16.17 | |||||
| PB Ratio | 2.51 | |||||
| Price-to-Tangible-Book | 2.82 | |||||
| EV-to-EBIT | -2.29 | |||||
| EV-to-EBITDA | -2.35 | |||||
| EV-to-Revenue | 15.56 | |||||
| EV-to-FCF | -2.3 | |||||
| Price-to-Net-Current-Asset-Value | 2.82 | |||||
| Earnings Yield (Greenblatt) % | -43.78 | |||||
| FCF Yield % | -36.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PExA AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.115 | ||
| EPS (TTM) (€) | -0.018 | ||
| Beta | 0 | ||
| Volatility % | 55.32 | ||
| 14-Day RSI | 49.93 | ||
| 14-Day ATR (€) | 0.003806 | ||
| 20-Day SMA (€) | 0.02818 | ||
| 12-1 Month Momentum % | -22.16 | ||
| 52-Week Range (€) | 0.0092 - 0.0468 | ||
| Shares Outstanding (Mil) | 58.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PExA AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PExA AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
PExA AB Frequently Asked Questions
What is PExA AB(FRA:FA0)'s stock price today?
The current price of FRA:FA0 is €0.03. The 52 week high of FRA:FA0 is €0.05 and 52 week low is €0.01.
When is next earnings date of PExA AB(FRA:FA0)?
The next earnings date of PExA AB(FRA:FA0) is 2024-11-08.
Does PExA AB(FRA:FA0) pay dividends? If so, how much?
PExA AB(FRA:FA0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers